Relationship between Toxoplasma Gondii and Psychotic Disorders with Implications toward a Brain-based Diagnostic System and Novel Treatment Approaches: A Study Protocol
Journal of Advances in Medicine and Medical Research,
What role infectious agents play in the causation of psychotic disorders? To investigate this area, we have aimed to investigate the relationship between Toxoplasma gondii and psychotic disorders. A hospital-based cross-sectional study is designed. IgM and IgG antibodies to T. gondii in patients with psychotic disorders will be measured and presented in result. Seropositivity rates will be compared with first-degree relatives and healthy volunteers. Also, types of psychotic disorders and seropositivity rate will be compared. Here, we are presenting the study protocol with implications toward a brain-based diagnostic system and novel treatment approaches.
- Toxoplasma gondii
- psychotic disorders
- diagnostic system
- seropositivity rate
How to Cite
Jones-Brando L, Torrey EF, Yolken R. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res. 2003;62(3):237-44. DOI: 10.1016/s0920-9964(02)00357-2. PMID: 12837520.
Abdollahian E, Shafiei R, Mokhber N, Kalantar K, Fata A. Seroepidemiological study of Toxoplasma gondii infection among psychiatric patients in Mashhad, Northeast of Iran. Iran J Parasitol. 2017;12(1):117-22. PMID: 28761468; PMCID: PMC5522687.
Chen X, Chen B, Hou X, Zheng C, Yang X, Ke J, et al. Association between Toxoplasma gondii infection and psychiatric disorders in Zhejiang, Southeastern China. Acta Trop. 2019;192:82-6. DOI: 10.1016/j.actatropica. 2019.02.001. Epub 2019 Feb 4. PMID: 30731066.
Yolken R, Torrey EF, Dickerson F. Evidence of increased exposure to Toxoplasma gondii in individuals with recent onset psychosis but not with established schizophrenia. PLoS Negl Trop Dis. 2017;11(11):e0006040. DOI: 10.1371/journal.pntd.0006040. PMID: 29108011; PMCID: PMC5690692.
World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.
Abd El-Aal NF, Saber M, Fawzy N, Ashour WR. Sero-prevalence of anti-Toxoplasma gondii antibodies among patients with neuropsychiatric disorders: epilepsy and depression. J Egypt Soc Parasitol. 2016;46(3):729-36. PMID: 30230768.
Yalın Sapmaz Ş, Şen S, Özkan Y, Kandemir H. Relationship between Toxoplasma gondii seropositivity and depression in children and adolescents. Psychiatry Res. 2019;278:263-7. DOI:10.1016/j.psychres.2019.06.031. Epub 2019 Jun 20. PMID: 31238296.
Sari SA, Kara A. Association of suicide attempt with seroprevalence of Toxoplasma gondii in adolescents. J Nerv Ment Dis. 2019;207(12):1025-30. DOI:10.1097/NMD.0000000000001046. PMID: 31688493.
Equator Network. SPIRIT 2013 Statement: Defining standard protocol items for clinical trials; 2021. Accessed 29 March 2021. Available: https://www.equator-network.or g/reporting-guidelines/spirit-2013-statement-defining-stand
Abstract View: 619 times
PDF Download: 264 times